ClinicalTrials.govpublic full text
Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity
polycystic ovary syndrome, weight gain, hba1c
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 180346
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.